| Authors: |
Lawson ARJ; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Abascal F; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Nicola PA; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Lensing SV; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.; Sequencing Operations, Wellcome Sanger Institute, Hinxton, UK., Roberts AL; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Kalantzis G; Human Genetics Programme, Wellcome Sanger Institute, Hinxton, UK., Baez-Ortega A; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Brzozowska N; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., El-Sayed Moustafa JS; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Vaitkute D; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Jakupovic B; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Nessa A; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Wadge S; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Österdahl MF; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Paterson AL; Department of Histopathology, Cambridge University Hospitals NHS Foundation Trust, Cambridge, UK., Rassl DM; Department of Pathology, Royal Papworth Hospital NHS Foundation Trust, Cambridge, UK., Alcantara RE; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.; Quotient Therapeutics Limited, Saffron Walden, UK., O'Neill L; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Widaa S; Sequencing Operations, Wellcome Sanger Institute, Hinxton, UK., Austin-Guest S; Sequencing Operations, Wellcome Sanger Institute, Hinxton, UK., Neville MDC; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Przybilla MJ; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Cheng W; Sequencing Operations, Wellcome Sanger Institute, Hinxton, UK., Morra M; Sequencing Operations, Wellcome Sanger Institute, Hinxton, UK., Sykes L; Sequencing Operations, Wellcome Sanger Institute, Hinxton, UK., Mayho M; Sequencing Operations, Wellcome Sanger Institute, Hinxton, UK., Müller-Sienerth N; Sequencing Operations, Wellcome Sanger Institute, Hinxton, UK., Williams N; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Alexander D; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Harvey LMR; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Clarke T; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Byrne A; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Blundell JR; Early Cancer Institute, University of Cambridge, Cambridge Biomedical Campus, Cambridge, UK., Young MD; Quotient Therapeutics Limited, Saffron Walden, UK., Mahbubani KTA; Department of Surgery, University of Cambridge, Cambridge, UK.; NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge, UK., Saeb-Parsy K; Department of Surgery, University of Cambridge, Cambridge, UK.; NIHR Cambridge Biomedical Research Centre, Cambridge Biomedical Campus, Cambridge, UK., Martin HC; Human Genetics Programme, Wellcome Sanger Institute, Hinxton, UK., Stratton MR; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Campbell PJ; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK.; Quotient Therapeutics Limited, Saffron Walden, UK., Rahbari R; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK., Small KS; Department of Twin Research and Genetic Epidemiology, King's College London, London, UK., Martincorena I; Cancer, Ageing and Somatic Mutation Programme, Wellcome Sanger Institute, Hinxton, UK. im3@sanger.ac.uk. |
